Immunoprecise Antibodies (IPA-TSX.V) Interview with CEO Dr. Jennifer Bath
Posted Sep 29, 2020, 6:50 PM UTC
71
Posted Sep 29, 2020, 6:50 PM UTC
SARS-CoV-2 initiatives could make them a billion dollar company overnight. CRO & Talem (aside from SARS-CoV-2) will also get them there, just will take longer. Company has the leadership, is cashed up, and has separated themselves in an exploding niche and industry.
[deleted]